Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT04065087 · WITHDRAWN
Trial details
- NCT number
- NCT04065087
- Sponsor
- Genexine, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2022-05-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.